Tech Company Financing Transactions

Sydnexis Funding Round

Bluestem Capital, Visionary Venture Fund and Longitude Capital Management participated in a $45 million Series B funding round for Sydnexis. The financing round was announced on 8/11/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

445 Marine View Ave. 295
Del Mar, CA 92014
USA

Phone

858-925-6172

Website

www.sydnexis.com

Email Address

[email protected]

Overview

Sydnexis Inc., is a privately held clinical stage biopharmaceutical company based in San Diego that is developing a proprietary formulation for decreasing myopic progression in children. Sydnexis recently initiated a Phase 3 study testing its patented eyedrop formulation, SYD-101.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ken Widder

        

Chief Operating Officer

Jacki Johnson

        

VP - Bus. Development

Patrick Johnson

        

Browse more venture capital transactions:

Prev: 8/11/2021: 80 Acres Farms venture capital transaction
Next: 8/11/2021: OwnBackup venture capital transaction

Share this article

News on VC Transactions

We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary